US$ 22.85
mechanism of glp 1 receptor agonist Frontiers Glucagon-Like Peptide-1 Receptor Agonists And
Description
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources

2014 Jun;51(3):491497

How Long Will Results Last

Obesity is a significant independent risk factor for CVDs, and chronic obesity can lead to cardiac dysfunction, progressing to obesity-related cardiomyopathy

PMID 40583149

Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, pla-cebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
